当前位置: 首页 > 详情页

Clinical characterization of an APP mutation (V717I) in five Han Chinese families with early-onset Alzheimer's disease

| 导出 | |

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, PR China [b]Center of Alzheimer's Disease, Beijing Institute for Brain Disorders, Beijing, PR China [c]Beijing Key Laboratory of Geriatric Cognitive Disorders, Beijing, PR China [d]Key Neurodegenerative Laboratory of Ministry of Education of the People's Republic of China, Beijing, PR China
出处:
ISSN:

关键词: Early-onset familial Alzheimer's disease APPV717I mutation Apolipoprotein E genotype Phenotype heterogeneity Copy number variations

摘要:
The missense mutation V717I in amyloid precursor protein (APP) gene has been reported in many early-onset familial Alzheimer's disease (EOFAD) families. However, no detailed clinical picture regarding this mutation has ever been described for Chinese EOFAD. We investigate the age at onset (AAO), initial clinical features and non-cognitive neurological symptoms in 34 affected subjects from five Han Chinese EOFAD families with the APPV717I mutation to characterize the clinical phenotype. The AAO was 54.7 +/- 4.9 years (n = 34), with the APOE epsilon 4 allele correlating with a decreased AAO. Prominent early affective symptoms, executive dysfunction and disorientation at onset were exhibited in 26 (76.5%), 18 (52.9%) and 16 (47%) cases, respectively. Spastic paraparesis and cerebellar ataxia occurred frequently in 13 (38.2%) and 12 (35.3%) cases, respectively, during the late stages of disease. The specific clinical phenotype of the APPV717I mutation for Chinese families is characterized by prominent early affective symptoms, executive dysfunction and disorientation as well as frequent late spastic paraparesis and cerebellar ataxia as compared to Western reports. We conclude that ethnic differences, environment or additional unknown factors may challenge the homogeneity of EOFAD with identical APP mutations. (C) 2016 Published by Elsevier B.V.

基金:
语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 4 区 临床神经病学 4 区 神经科学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 临床神经病学 3 区 神经科学
JCR分区:
出版当年[2015]版:
Q3 NEUROSCIENCES Q3 CLINICAL NEUROLOGY
最新[2023]版:
Q1 CLINICAL NEUROLOGY Q2 NEUROSCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [a]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing, PR China
通讯作者:
通讯机构: [*1]Department of Neurology, Xuan Wu Hospital, Capital Medical University, Beijing 100053, PR China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:16409 今日访问量:0 总访问量:869 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院